Hydrazinecarboxamide

Hydrazinecarboxamide

SCHEMBL4712502

NNC(N)=O.O=Cc1nc2ccccc2cc1-c1ncc[nH]1

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK1A1 P48729 1/20 0.46
TYRO3 Q06418 1/20 0.46
DYRK1B Q9Y463 1/20 0.46
CASP1 P29466 1/20 0.36
ADRA2A P08913 2/20 0.35
ALDH1A1 P00352 3/20 0.35
GAA P10253 2/20 0.35
MAPT P10636 2/20 0.35
KDM4E B2RXH2 2/20 0.35
POLB P06746 1/20 0.35
ADRA2B P18089 1/20 0.35
ADRA2C P18825 1/20 0.35
IKBKB O14920 1/20 0.35
AKT1 P31749 2/20 0.34
AKT2 P31751 2/20 0.34
PARP1 P09874 1/20 0.34
PIK3CD O00329 3/20 0.34
HDAC3 O15379 1/20 0.33
NCOR1 O75376 1/20 0.33
HDAC1 Q13547 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2563442 0.89 ADRA2A (0.42) CSNK1A1TYRO3DYRK1BCASP1ADRA2A
SCHEMBL30979447 0.70 ADRA2A (0.46) CSNK1A1TYRO3DYRK1BADRA2AALDH1A1
SCHEMBL4329170 0.68 ADRA2A (0.50) CSNK1A1TYRO3DYRK1BCASP1ADRA2A
SCHEMBL6824177 0.66 MTOR (0.54) CSNK1A1TYRO3DYRK1BADRA2AALDH1A1
SCHEMBL28678460 0.66 ALDH1A1 (0.47) ALDH1A1GAAMAPTKDM4EAKT1
SCHEMBL39553 0.65 ALDH1A1 (0.47) CSNK1A1TYRO3DYRK1BADRA2AALDH1A1
SCHEMBL9603839 0.64 SMN1; SMN2 (0.48) CSNK1A1TYRO3DYRK1BADRA2AALDH1A1
SCHEMBL6825869 0.64 CSNK1A1 (1.00) CSNK1A1TYRO3DYRK1BALDH1A1KDM4E
SCHEMBL1663671 0.63 CSNK1A1 (0.53) CSNK1A1TYRO3DYRK1BADRA2AALDH1A1
SCHEMBL21298118 0.63 ADRA2A (0.49) CSNK1A1TYRO3DYRK1BCASP1ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1888060-A2 NK-B INHIBITORS FOR THE TREATMENT OF MUSCULAR DYSTROPHY A. T. Still University of Health Sciences (US) 2008-02-20 EP claimed
US-20060280812-A1 Compositions and methods for the treatment of muscular dystrophy A.T. STILL UNIVERSITY OF HEATH SCIENCES 2006-12-14 US claimed
WO-2006127930-A2 NK-B INHIBITORS FOR THE TREATMENT OF MUSCULAR DYSTROPHY A. T. STILL UNIVERSITY OF HEALTH SCIENCES (US) 2006-11-30 WO claimed